Close the merger of IFF and DuPont’s Nutrition & Biosciences business

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced: 16 Dec 2019
Due: 31 Mar 2021
Delivered: 1 Feb 2021

Deadline
Met
Late
Not met
Today

What the company said

“The parties target closing the deal by the end of the first quarter of 2021.”

SourceDuPont Form 8-K press release, 2019-12-16
FilingSEC filing index
Deadline as statedby the end of the first quarter of 2021
Deadline used31 Mar 2021, the last day of the stated period
TypeTransaction
Permanent referenceKI-C-2019-DD-007439
Cite as https://keptindex.org/c/KI-C-2019-DD-007439/ — this address never changes.

What we found

Evidence strength A What the grades mean

DuPont completed the merger of its Nutrition & Biosciences business with IFF on February 1, 2021, which is before the deadline of March 31, 2021.

A
DuPont 10-Q filed 2021-05-04 Regulatory filing · published 4 May 2021 · retrieved 12 Oct 2026 · kept permanently by the SEC · fingerprint 37a893095859
“On February 1, 2021, DuPont completed the separation and distribution of the Nutrition & Biosciences business segment (the "N&B Business"), and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrance” ✓ confirmed on the page

Market reaction: the shares moved +3.8% against the S&P 500 over the three sessions around the disclosure (3 May 2021 to 6 May 2021). What this measures

Checked 12 Oct 2026.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

Language weakened: firm → expected
3 versions

Version 1 · original · stated 16 Dec 2019

Deadline 31 Mar 2021 (“by the end of the first quarter of 2021”)
Version 2 · stated 5 May 2020

Deadline 31 Mar 2021 (“1Q 2021”) · wording firm

“The combination of our Nutrition & Biosciences business with IFF remains on track for a 1Q 2021 closing”
Source for this version
Version 3 · stated 7 Dec 2020

Deadline 31 Mar 2021 (“first quarter of 2021”) · wording expected

“IFF and DuPont continue to expect to close the transaction in the first quarter of 2021.”
Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Merger
Indicative materiality: Transformational rules
Action: Close
Deliverable: merger of IFF and DuPont’s Nutrition & Biosciences business
In the company’s control: Medium
Specificity: High
Conditional: Yes: subject to approval by IFF shareholders; subject to regulatory approvals
Depends on: Regulatory, Shareholder

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you DuPont? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.